Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/08

Curator: Joiejoie

Revision editor(s): Joiejoie, Mautin, Anne-mariesharp

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces , Caecum Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces,Blind intestine,Blindgut,Caeca,Caecum,Ceca,Cecum,Intestinum caecum,Intestinum crassum caecum,Intestinum crassum cecum,caecum
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Sampling site Sampling site,sampling site
Group 0 name Corresponds to the control (unexposed) group for case-control studies
CMB1 (Constipation mice treated with CMB1 with adhesion properties) (fecal sample)
Group 1 name Corresponds to the case (exposed) group for case-control studies
C-CMB1 (Constipation mice treated with CMB1 with adhesion properties) (cecal sample)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 10^10 CFU/mL CMB1(Combined multiple strains of Bifidobacterium with adhesion property), respectively, daily for 2 weeks and loperamide (0.25 mL) intragastrically from day 15 to day 17 to induce constipation.
Group 0 sample size Number of subjects in the control (unexposed) group
8
Group 1 sample size Number of subjects in the case (exposed) group
8

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
log transformation
Statistical test
ANOVA
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05


Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/12

Curator: Joiejoie

Revision editor(s): Joiejoie, Mautin

Source: Figure 9,10,11

Description: The genus-level comparison of fecal samples and caecum content samples.

Abundance in Group 1: increased abundance in C-CMB1 (Constipation mice treated with CMB1 with adhesion properties) (cecal sample)

NCBI Quality ControlLinks
Akkermansia
Anaeroplasma
Bacteroides
Clostridium
Mucispirillum
Oscillospira
Parabacteroides
Rikenella
Ruminococcus
unclassified Helicobacteraceae
unclassified Lachnospiraceae
Dorea

Revision editor(s): Joiejoie, Mautin

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/23

Curator: Mautin

Revision editor(s): Mautin

Source: Figure 9,10,11

Description: The genus-level comparison of fecal samples and caecum content samples.

Abundance in Group 1: decreased abundance in C-CMB1 (Constipation mice treated with CMB1 with adhesion properties) (cecal sample)

NCBI Quality ControlLinks
Bifidobacterium
Lactobacillus
Odoribacter

Revision editor(s): Mautin